| Insulin-like growth factor binding protein 5 |
Igfbp5 |
−7.1 |
−3.1 |
| Procollagen, Type XII, Alpha 1 |
Col12a1 |
−6.3 |
−4.3 |
| Matrix metallopeptidase 8 |
Mmp8 |
−4.8 |
−2.5 |
| Core binding factor beta |
Cbfb |
−4.6 |
−2.4 |
| Caveolin |
Cav |
−4.6 |
−3.7 |
| Transforming growth factor, beta receptor II |
Tgfbr2 |
−4.0 |
−4.2 |
| Leptin receptor |
Lepr |
−4.0 |
−2.1 |
| Wingless-type MMTV integration site 5A |
Wnt5a |
−3.8 |
−1.0 |
| Bone morphogenetic protein 6 |
Bmp6 |
−3.8 |
−1.4 |
| MAD homolog 6 (Drosophila) |
Smad6 |
−3.8 |
−1.2 |
| Osteoglycin |
Ogn |
−3.7 |
−1.9 |
| Bone morphogenic protein receptor, type II |
Bmpr2 |
−3.7 |
−2.9 |
| MAD homolog 7 |
Smad7 |
−3.7 |
−2.2 |
| Transforming growth factor, beta receptor III |
Tgfbr3 |
−3.7 |
−3.2 |
| Insulin-like growth factor binding protein 7 |
Igfbp7 |
−3.1 |
−1.0 |
| Catenin (Cadherin Associated Protein), beta 1 |
Ctnnb1 |
−3.1 |
−1.4 |
| CD276 antigen |
Cd276 |
−3.1 |
−3.1 |
| Parathyroid hormone receptor 2 |
Pthr2 |
−2.9 |
−1.4 |
| Fibroblast growth factor receptor 2 |
Fgfr2 |
−2.9 |
−1.2 |
| Fibroblast growth factor 9 |
Fgf9 |
−2.9 |
−0.8 |
| Calcitonin receptor |
Calcr |
−2.8 |
−2.6 |
| MAD homolog 4 (Drosophila) |
Smad4 |
−2.7 |
−1.1 |
| Fibroblast growth factor 5 |
Fgf5 |
−2.5 |
−3.7 |
| Procollagen, Type III, Alpha 1 |
Col3a1 |
−2.5 |
−0.8 |
| MAD homolog 9 (Drosophila) |
Smad9 |
−2.3 |
−0.1 |
| Matrix metallopeptidase 7 |
Mmp7 |
−2.3 |
−3.0 |
| 3-Hydroxy-3-methylglutaryl-coenzyme A reductase |
Hmgcr |
−2.3 |
−1.0 |
| MAD homolog 5 (Drosophila) |
Smad5 |
−2.2 |
−2.0 |
| Interleukin 6 signal transducer |
Il6st |
−2.2 |
−1.7 |
| Fibroblast growth factor 8 |
Fgf8 |
−2.1 |
−0.7 |
| Apolipoprotein E |
Apoe |
−2.0 |
−1.4 |
| Procollagen, Type I, Alpha 2 |
Col1a2 |
−1.8 |
−0.4 |
| Cbp/P300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 1 |
Cited1 |
2.1 |
0.9 |
| Interleukin 6 |
IL6 |
2.2 |
3.0 |
| Interferon beta 1 |
Ifnb1 |
3.1 |
1.3 |
| Advanced glycosylation end product-specific receptor |
Ager |
4.6 |
4.2 |
